Early use of intravenous beta-blockers in acute MI and beta-blocker therapy initiated before hospital discharge and continued for a minimum of 1 year have shown reduced mortality and re-infarction in patients who have had a myocardial infarction. In fact the success of this therapy is better in women than men. However, beta-blockers are often under prescribed in women post-infarction . The under usage of beta-blockers is associated with advanced age. Whereby, older patients are less likely to be treated with beta-blocker therapy than younger patients.